FI973356A0 - Inhibition of angiogenesis using interleukin-12 - Google Patents

Inhibition of angiogenesis using interleukin-12

Info

Publication number: FI973356A0
Authority: FI; Finland
Prior art keywords: angiogenesis; interleukin; inhibition
Prior art date: 1995-02-16

Application number

FI973356A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI973356L (en

Inventor

Moses Judah Folkman

Gary Arthur Truitt

Emile Eugene Voest

Original Assignee

Hoffmann La Roche

Childrens Medical Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-16

Filing date

1997-08-15

Publication date

1997-08-15

1997-08-15 Application filed by Hoffmann La Roche, Childrens Medical Center filed Critical Hoffmann La Roche

1997-08-15 Publication of FI973356A0 publication Critical patent/FI973356A0/en

1997-08-15 Publication of FI973356L publication Critical patent/FI973356L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Zoology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FI973356A 1995-02-16 1997-08-15 Inhibition of angiogenesis using interleukin-12 FI973356L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38938295A	1995-02-16	1995-02-16
PCT/EP1996/000507 WO1996025171A1 (en)	1995-02-16	1996-02-07	Inhibition of angiogenesis using interleukin-12

Publications (2)

Publication Number	Publication Date
FI973356A0 true FI973356A0 (en)	1997-08-15
FI973356L FI973356L (en)	1997-08-15

Family

ID=23538033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI973356A FI973356L (en)	1995-02-16	1997-08-15	Inhibition of angiogenesis using interleukin-12

Country Status (8)

Country	Link
EP (1)	EP0809511A1 (en)
JP (1)	JPH11500119A (en)
AU (1)	AU4788396A (en)
BR (1)	BR9607427A (en)
CA (1)	CA2212370A1 (en)
FI (1)	FI973356L (en)
TR (1)	TR199700801T1 (en)
WO (1)	WO1996025171A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998022129A1 (en) *	1996-11-22	1998-05-28	Toray Industries, Inc.	Therapeutic agent for ophthalmic diseases
US5858991A (en)	1997-01-29	1999-01-12	Vanderbilt University	Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) *	1997-01-29	1999-11-09	Vanderbilt University	Facilitation of repair of neural injury with CM101/GBS toxin
US6028060A (en) *	1997-01-29	2000-02-22	Vanderbilt University	Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en)	1998-01-29	2003-12-30	Yeda Reaearch And Development Co., Ltd.	Facilitation of wound healing with CM101/GBS toxin
US6660258B1 (en)	1997-05-09	2003-12-09	Pharma Pacific Pty Ltd	Oromucosal cytokine compositions and uses thereof
WO1998053835A1 (en) *	1997-05-27	1998-12-03	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
EP1030681A4 (en) *	1997-11-03	2001-07-04	Wistar Inst	METHOD AND COMPOSITIONS FOR INHIBITING ANGIOGENESIS AND TREATING CANCER
EP1373206B1 (en)	2001-03-29	2008-12-24	Schering Corporation	Aryl oxime-piperazines useful as ccr5 antagonists
AU2003292838A1 (en) *	2002-12-27	2004-07-29	Kirin Beer Kabushiki Kaisha	Therapeutic agent for wet age-related macular degeneration
MXPA05010081A (en)	2003-03-24	2005-11-23	Hoffmann La Roche	Benzyl-pyridazinons as reverse transcriptase inhibitors.
WO2007045573A1 (en)	2005-10-19	2007-04-26	F. Hoffmann-La Roche Ag	Phenyl-acetamide nnrt inhibitors
KR101401811B1 (en)	2006-08-16	2014-05-29	에프. 호프만-라 로슈 아게	Non-nucleoside reverse transcriptase inhibitors
ES2550152T3 (en)	2006-12-13	2015-11-04	F. Hoffmann-La Roche Ag	2- (Piperidin-4-yl) -4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
CN109789187A (en) *	2016-07-18	2019-05-21	创新疗法医药有限公司	Purposes of the IL-12 as substitution immunotherapeutic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0576669A4 (en) *	1992-01-16	1996-05-08	Repligen Corp	Novel methods and compositions for treatment of angiogenic diseases
JPH06157344A (en) *	1992-02-07	1994-06-03	Childrens Medical Center Corp:The	Pharmaceutical formulation for inhibiting angiogenesis and method for inhibiting angiogenesis

1996
- 1996-02-07 CA CA002212370A patent/CA2212370A1/en not_active Abandoned
- 1996-02-07 WO PCT/EP1996/000507 patent/WO1996025171A1/en not_active Application Discontinuation
- 1996-02-07 TR TR97/00801T patent/TR199700801T1/en unknown
- 1996-02-07 JP JP8524631A patent/JPH11500119A/en active Pending
- 1996-02-07 EP EP96904008A patent/EP0809511A1/en not_active Withdrawn
- 1996-02-07 BR BR9607427A patent/BR9607427A/en not_active Application Discontinuation
- 1996-02-07 AU AU47883/96A patent/AU4788396A/en not_active Abandoned
1997
- 1997-08-15 FI FI973356A patent/FI973356L/en unknown

Also Published As

Publication number	Publication date
WO1996025171A1 (en)	1996-08-22
FI973356L (en)	1997-08-15
JPH11500119A (en)	1999-01-06
AU4788396A (en)	1996-09-04
TR199700801T1 (en)	1998-03-21
MX9706188A (en)	1997-11-29
BR9607427A (en)	1998-06-23
CA2212370A1 (en)	1996-08-22
EP0809511A1 (en)	1997-12-03

Publication	Publication Date	Title
ATE230389T1 (en)	2003-01-15	ANGIOGENESIS INHIBITORS
NO986052D0 (en)	1998-12-22	Anticonvulsant derivatives for the treatment of obesity
EE03354B1 (en)	2001-02-15	Process for the synthesis of substituted sulfoxides
PL322277A1 (en)	1998-01-19	Derivatives of pyrazol-4-ylobenzoyl
BR9612465A (en)	1999-07-13	Heterocyclic compounds
DE69621066D1 (en)	2002-06-13	Borehole Zementierungswerkzeug
BR9609797A (en)	1999-03-16	Inhibition of gene expression
FI973356A0 (en)	1997-08-15	Inhibition of angiogenesis using interleukin-12
DK0815348T3 (en)	2001-10-22	Hydrate inhibition
PL324451A1 (en)	1998-05-25	Derivatives of diphenylmethylenepiperidine
BR9609726A (en)	1999-03-16	Inhibition of gene expression
HUP9602510A1 (en)	1997-05-28	Preparation of substituted thiazoles
DK0815341T3 (en)	2000-09-25	Double borehole riser
GB9621852D0 (en)	1996-12-11	Inhibition of scale
BR9607046A (en)	1997-12-30	Derivatives of 3-pyrrolidiliden-2-one-cephalosporins
NO980862D0 (en)	1998-02-27	Zwitterinoforms of trovafloxacin
GB9510563D0 (en)	1995-07-19	Well inhibition
IS4339A (en)	1996-10-25	Photocompetition inhibition of 3-substituted-2-oxindoles
KR970009863U (en)	1997-03-29	Shower rack
GB2305172B (en)	1998-11-18	Preparation of substituted thiazoles
KR950024188U (en)	1995-09-13	Brackets of Anchorfish
GB9515060D0 (en)	1995-09-20	Therapeutic heterocyclic compounds
PT761766E (en)	2002-09-30	ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE
GB9521509D0 (en)	1995-12-20	Inhibition of scale
FI955924A0 (en)	1995-12-11	Rengoering av skivvaermevaexlare med effektultraljud